Published in Yonsei Med J on April 01, 2014
Agmatine Ameliorates High Glucose-Induced Neuronal Cell Senescence by Regulating the p21 and p53 Signaling. Exp Neurobiol (2016) 0.76
Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease. Yonsei Med J (2017) 0.75
Myricetin protects hippocampal CA3 pyramidal neurons and improves learning and memory impairments in rats with Alzheimer's disease. Neural Regen Res (2016) 0.75
Treadmill exercise ameliorates symptoms of Alzheimer disease through suppressing microglial activation-induced apoptosis in rats. J Exerc Rehabil (2016) 0.75
Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods (1984) 16.43
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med (1997) 7.56
Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med (2004) 5.88
Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci U S A (1996) 5.15
Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem (1999) 4.77
Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol (2001) 4.43
Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol (1994) 3.19
Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc Natl Acad Sci U S A (1993) 3.16
PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol (2001) 3.15
Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature (1994) 2.96
Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem (2001) 2.42
Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis (2001) 2.02
Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ (1999) 1.97
Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J Alzheimers Dis (2006) 1.82
Insulin and the insulin receptor in experimental models of learning and memory. Eur J Pharmacol (2004) 1.74
Insulin signaling in the central nervous system: learning to survive. Prog Neurobiol (2006) 1.69
Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol (2000) 1.69
Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J Pathol (2011) 1.63
Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry (1999) 1.57
Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci (1998) 1.56
Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol (2004) 1.52
beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. J Biol Chem (2006) 1.50
beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends Neurosci (1993) 1.48
Pharmacologic management of Alzheimer disease, Part I: Hormonal and emerging investigational drug therapies. Ann Pharmacother (1999) 1.40
Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement (2008) 1.39
Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci (2000) 1.39
Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem (2007) 1.37
Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav (2000) 1.36
Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease. FASEB J (2009) 1.36
Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1--42) and A beta(25--35). J Am Chem Soc (2001) 1.32
Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium (2010) 1.29
Agmatine : metabolic pathway and spectrum of activity in brain. CNS Drugs (2007) 1.25
Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev (2001) 1.24
Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci (2002) 1.23
Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J Neurochem (2005) 1.20
Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2. J Neurosci (2008) 1.18
Amyloid β peptide oligomers directly activate NMDA receptors. Cell Calcium (2011) 1.15
Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Exp Neurol (2004) 1.14
Oxidative stress in Alzheimer's disease. Neurobiol Aging (2005) 1.12
The parahippocampal gyrus in Alzheimer's disease. Clinical and preclinical neuroanatomical correlates. Ann N Y Acad Sci (2000) 1.12
Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav Brain Res (2006) 1.10
Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci (2001) 1.10
Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm Suppl (2007) 1.10
Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease. Biochem Soc Trans (2012) 1.04
Selenium protects cerebral ischemia in rat brain mitochondria. Biol Trace Elem Res (2004) 1.01
Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem (2005) 1.01
Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol (1989) 1.01
Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation. J Pharmacol Exp Ther (1996) 0.99
Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res (2004) 0.99
Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons. Brain Res (2006) 0.97
Agmatine: clinical applications after 100 years in translation. Drug Discov Today (2013) 0.96
Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res (2002) 0.95
Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci (2006) 0.94
Aberrant insulin receptor signaling and amino acid homeostasis as a major cause of oxidative stress in aging. Antioxid Redox Signal (2008) 0.94
Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity. J Neural Transm (Vienna) (2003) 0.93
Agmatine prevents LPS-induced spatial memory impairment and hippocampal apoptosis. Eur J Pharmacol (2010) 0.92
Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicity. Cell Death Dis (2012) 0.92
Age-related changes of Nrf2 and phosphorylated GSK-3β in a mouse model of accelerated aging (SAMP8). Arch Gerontol Geriatr (2011) 0.92
Protective effect of melatonin on beta-amyloid-induced apoptosis in rat astroglioma C6 cells and its mechanism. Free Radic Biol Med (2004) 0.88
Role of oxidative stress on beta-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: protection by antioxidants. Exp Neurol (2006) 0.87
Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways. Cardiovasc Drugs Ther (2012) 0.87
Agmatine: a novel neurotransmitter? Adv Pharmacol (1998) 0.86
Hippocampal programmed cell death after status epilepticus: evidence for NMDA-receptor and ceramide-mediated mechanisms. Epilepsia (2003) 0.85
Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats. Ann N Y Acad Sci (1999) 0.85
Amyloid beta protein-induced irreversible current in rat cortical neurones. Neuroreport (1994) 0.84
Retroviral expression of arginine decarboxylase attenuates oxidative burden in mouse cortical neural stem cells. Stem Cells Dev (2010) 0.84
Learning and memory in agmatine-treated rats. Pharmacol Biochem Behav (2002) 0.84
Potential impact of genetic variants in Nrf2 regulated antioxidant genes and risk prediction of diabetes and associated cardiac complications. Curr Med Chem (2013) 0.84
Protective effects of agmatine on lipopolysaccharide-injured microglia and inducible nitric oxide synthase activity. Life Sci (2012) 0.83
Alzheimer's disease. Annu Rev Public Health (1989) 0.82
Targeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE Pathway. Int J Alzheimers Dis (2011) 0.82
Agmatine facilitates memory of an inhibitory avoidance task in adult rats. Neurobiol Learn Mem (2002) 0.82
Increased levels of antigen-bound β-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer's disease patients. PLoS One (2013) 0.82
Differential effects of i.c.v. microinfusion of agmatine on spatial working and reference memory in the rat. Neuroscience (2009) 0.81
Behavioral effects of agmatine in naive rats are task- and delay-dependent. Neuroscience (2009) 0.80
Agmatine inhibits morphine-induced memory impairment in the mouse step-down inhibitory avoidance task. Pharmacol Biochem Behav (2010) 0.80
Overexpression of human arginine decarboxylase rescues human mesenchymal stem cells against H₂O₂ toxicity through cell survival protein activation. J Korean Med Sci (2013) 0.80
Treadmill training restores spatial cognitive deficits and neurochemical alterations in the hippocampus of rats submitted to an intracerebroventricular administration of streptozotocin. J Neural Transm (Vienna) (2010) 0.80
Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment. Arzneimittelforschung (1995) 0.79
Vitamin E use is associated with improved survival in an Alzheimer's disease cohort. Dement Geriatr Cogn Disord (2009) 0.79
The effects of soluble Aβ oligomers on neurodegeneration in Alzheimer's disease. Curr Pharm Des (2014) 0.79
Bcl-2 overexpression protects against amyloid-beta and prion toxicity in GT1-7 neural cells. J Alzheimers Dis (2007) 0.78
Effects of nicorandil in neuroprotective activation of PI3K/AKT pathways in a cellular model of Alzheimer's disease. Eur Neurol (2013) 0.78
Change of Nrf2 expression in rat hippocampus in a model of chronic cerebral hypoperfusion. Int J Neurosci (2013) 0.77
Agmatine levels in the cerebrospinal fluid of normal human volunteers. J Pain Palliat Care Pharmacother (2009) 0.76
Perfusion of brain tissues with fixative. CSH Protoc (2008) 0.76
Anti-oxidants and cognitive function: a review of clinical and epidemiologic studies. J Neural Transm Suppl (1998) 0.75
Agmatine Attenuates Brain Edema and Apoptotic Cell Death after Traumatic Brain Injury. J Korean Med Sci (2015) 0.79
Adiponectin as a new paradigm for approaching Alzheimer's disease. Anat Cell Biol (2013) 0.79
Biocompatability of carbon nanotubes with stem cells to treat CNS injuries. Anat Cell Biol (2013) 0.77
Suppression of MicroRNA let-7a Expression by Agmatine Regulates Neural Stem Cell Differentiation. Yonsei Med J (2016) 0.75
The association between PGC-1α and Alzheimer's disease. Anat Cell Biol (2016) 0.75